Osilaris™ for Controlled, Scalable Cell Expansion: Supporting Process Robustness from Development to Manufacturing
- Addressing the limitations of conventional 2D expansion workflows when cell therapy processes need to move towards closed, scalable and reproducible manufacturing
- Exploring how Osilaris™ supports controlled low-shear expansion with in-line process control to help maintain process-relevant quality attributes
- Discussing how automation-ready bioreactor processing can support clinical-to-commercial progression, decentralised manufacturing models and lower process variability